nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Tachycardia—Tacrolimus—atopic dermatitis	0.00131	0.00131	CcSEcCtD
Deferoxamine—Skin disorder—Tacrolimus—atopic dermatitis	0.00131	0.00131	CcSEcCtD
Deferoxamine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.0013	CcSEcCtD
Deferoxamine—Dizziness—Loratadine—atopic dermatitis	0.0013	0.0013	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.00129	0.00129	CcSEcCtD
Deferoxamine—Hypotension—Tacrolimus—atopic dermatitis	0.00126	0.00126	CcSEcCtD
Deferoxamine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00125	0.00125	CcSEcCtD
Deferoxamine—Vomiting—Loratadine—atopic dermatitis	0.00125	0.00125	CcSEcCtD
Deferoxamine—Infestation NOS—Methylprednisolone—atopic dermatitis	0.00124	0.00124	CcSEcCtD
Deferoxamine—Infestation—Methylprednisolone—atopic dermatitis	0.00124	0.00124	CcSEcCtD
Deferoxamine—Headache—Loratadine—atopic dermatitis	0.00123	0.00123	CcSEcCtD
Deferoxamine—Bradycardia—Prednisolone—atopic dermatitis	0.00123	0.00123	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00123	0.00123	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Deferoxamine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Deferoxamine—Paraesthesia—Tacrolimus—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Deferoxamine—Bradycardia—Hydrocortisone—atopic dermatitis	0.0012	0.0012	CcSEcCtD
Deferoxamine—Dyspnoea—Tacrolimus—atopic dermatitis	0.0012	0.0012	CcSEcCtD
Deferoxamine—Pruritus—Mometasone—atopic dermatitis	0.0012	0.0012	CcSEcCtD
Deferoxamine—Hallucination—Hydrocortisone—atopic dermatitis	0.00118	0.00118	CcSEcCtD
Deferoxamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00117	0.00117	CcSEcCtD
Deferoxamine—Nausea—Loratadine—atopic dermatitis	0.00117	0.00117	CcSEcCtD
Deferoxamine—Visual impairment—Prednisolone—atopic dermatitis	0.00117	0.00117	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Deferoxamine—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Deferoxamine—Diarrhoea—Mometasone—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Deferoxamine—Pain—Tacrolimus—atopic dermatitis	0.00115	0.00115	CcSEcCtD
Deferoxamine—Bradycardia—Triamcinolone—atopic dermatitis	0.00113	0.00113	CcSEcCtD
Deferoxamine—Bradycardia—Methylprednisolone—atopic dermatitis	0.00113	0.00113	CcSEcCtD
Deferoxamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00113	0.00113	CcSEcCtD
Deferoxamine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00111	0.00111	CcSEcCtD
Deferoxamine—Hallucination—Methylprednisolone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Deferoxamine—Eye disorder—Hydrocortisone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Deferoxamine—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00109	0.00109	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisolone—atopic dermatitis	0.00108	0.00108	CcSEcCtD
Deferoxamine—Vomiting—Mometasone—atopic dermatitis	0.00107	0.00107	CcSEcCtD
Deferoxamine—Visual impairment—Methylprednisolone—atopic dermatitis	0.00107	0.00107	CcSEcCtD
Deferoxamine—Urticaria—Tacrolimus—atopic dermatitis	0.00107	0.00107	CcSEcCtD
Deferoxamine—Immune system disorder—Hydrocortisone—atopic dermatitis	0.00107	0.00107	CcSEcCtD
Deferoxamine—Body temperature increased—Tacrolimus—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Deferoxamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Deferoxamine—Headache—Mometasone—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Deferoxamine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Deferoxamine—Erythema—Prednisolone—atopic dermatitis	0.00105	0.00105	CcSEcCtD
Deferoxamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.00105	CcSEcCtD
Deferoxamine—Eye disorder—Methylprednisolone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Deferoxamine—Erythema—Hydrocortisone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Deferoxamine—Bradycardia—Dexamethasone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Deferoxamine—Bradycardia—Betamethasone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Deferoxamine—Angiopathy—Methylprednisolone—atopic dermatitis	0.00101	0.00101	CcSEcCtD
Deferoxamine—Hallucination—Dexamethasone—atopic dermatitis	0.001	0.001	CcSEcCtD
Deferoxamine—Hallucination—Betamethasone—atopic dermatitis	0.001	0.001	CcSEcCtD
Deferoxamine—Nausea—Mometasone—atopic dermatitis	0.001	0.001	CcSEcCtD
Deferoxamine—Immune system disorder—Methylprednisolone—atopic dermatitis	0.001	0.001	CcSEcCtD
Deferoxamine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.001	0.001	CcSEcCtD
Deferoxamine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000993	0.000993	CcSEcCtD
Deferoxamine—Vision blurred—Prednisolone—atopic dermatitis	0.000992	0.000992	CcSEcCtD
Deferoxamine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000991	0.000991	CcSEcCtD
Deferoxamine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000991	0.000991	CcSEcCtD
Deferoxamine—Visual impairment—Betamethasone—atopic dermatitis	0.000972	0.000972	CcSEcCtD
Deferoxamine—Visual impairment—Dexamethasone—atopic dermatitis	0.000972	0.000972	CcSEcCtD
Deferoxamine—Erythema—Triamcinolone—atopic dermatitis	0.000968	0.000968	CcSEcCtD
Deferoxamine—Erythema—Methylprednisolone—atopic dermatitis	0.000966	0.000966	CcSEcCtD
Deferoxamine—Angioedema—Prednisolone—atopic dermatitis	0.000962	0.000962	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Prednisone—atopic dermatitis	0.00096	0.00096	CcSEcCtD
Deferoxamine—Pruritus—Tacrolimus—atopic dermatitis	0.000952	0.000952	CcSEcCtD
Deferoxamine—Eye disorder—Dexamethasone—atopic dermatitis	0.000943	0.000943	CcSEcCtD
Deferoxamine—Eye disorder—Betamethasone—atopic dermatitis	0.000943	0.000943	CcSEcCtD
Deferoxamine—Angioedema—Hydrocortisone—atopic dermatitis	0.000939	0.000939	CcSEcCtD
Deferoxamine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00092	0.00092	CcSEcCtD
Deferoxamine—Angiopathy—Betamethasone—atopic dermatitis	0.000915	0.000915	CcSEcCtD
Deferoxamine—Angiopathy—Dexamethasone—atopic dermatitis	0.000915	0.000915	CcSEcCtD
Deferoxamine—Convulsion—Prednisolone—atopic dermatitis	0.000912	0.000912	CcSEcCtD
Deferoxamine—Arrhythmia—Dexamethasone—atopic dermatitis	0.000901	0.000901	CcSEcCtD
Deferoxamine—Arrhythmia—Betamethasone—atopic dermatitis	0.000901	0.000901	CcSEcCtD
Deferoxamine—Bradycardia—Prednisone—atopic dermatitis	0.000895	0.000895	CcSEcCtD
Deferoxamine—Convulsion—Hydrocortisone—atopic dermatitis	0.000891	0.000891	CcSEcCtD
Deferoxamine—Dizziness—Tacrolimus—atopic dermatitis	0.000889	0.000889	CcSEcCtD
Deferoxamine—Angioedema—Triamcinolone—atopic dermatitis	0.000885	0.000885	CcSEcCtD
Deferoxamine—Angioedema—Methylprednisolone—atopic dermatitis	0.000883	0.000883	CcSEcCtD
Deferoxamine—Erythema—Betamethasone—atopic dermatitis	0.000878	0.000878	CcSEcCtD
Deferoxamine—Erythema—Dexamethasone—atopic dermatitis	0.000878	0.000878	CcSEcCtD
Deferoxamine—Myalgia—Hydrocortisone—atopic dermatitis	0.000875	0.000875	CcSEcCtD
Deferoxamine—Hallucination—Prednisone—atopic dermatitis	0.000874	0.000874	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000869	0.000869	CcSEcCtD
Deferoxamine—Connective tissue disorder—Prednisone—atopic dermatitis	0.000864	0.000864	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000859	0.000859	CcSEcCtD
Deferoxamine—Oedema—Prednisolone—atopic dermatitis	0.000859	0.000859	CcSEcCtD
Deferoxamine—Vomiting—Tacrolimus—atopic dermatitis	0.000855	0.000855	CcSEcCtD
Deferoxamine—Shock—Prednisolone—atopic dermatitis	0.000845	0.000845	CcSEcCtD
Deferoxamine—Headache—Tacrolimus—atopic dermatitis	0.000843	0.000843	CcSEcCtD
Deferoxamine—Oedema—Hydrocortisone—atopic dermatitis	0.000839	0.000839	CcSEcCtD
Deferoxamine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000839	0.000839	CcSEcCtD
Deferoxamine—Convulsion—Triamcinolone—atopic dermatitis	0.000839	0.000839	CcSEcCtD
Deferoxamine—Tachycardia—Prednisolone—atopic dermatitis	0.000838	0.000838	CcSEcCtD
Deferoxamine—Convulsion—Methylprednisolone—atopic dermatitis	0.000837	0.000837	CcSEcCtD
Deferoxamine—Infection—Hydrocortisone—atopic dermatitis	0.000834	0.000834	CcSEcCtD
Deferoxamine—Shock—Hydrocortisone—atopic dermatitis	0.000826	0.000826	CcSEcCtD
Deferoxamine—Myalgia—Triamcinolone—atopic dermatitis	0.000824	0.000824	CcSEcCtD
Deferoxamine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000823	0.000823	CcSEcCtD
Deferoxamine—Myalgia—Methylprednisolone—atopic dermatitis	0.000822	0.000822	CcSEcCtD
Deferoxamine—Arthralgia—Methylprednisolone—atopic dermatitis	0.000822	0.000822	CcSEcCtD
Deferoxamine—Eye disorder—Prednisone—atopic dermatitis	0.000821	0.000821	CcSEcCtD
Deferoxamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000819	0.000819	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000817	0.000817	CcSEcCtD
Deferoxamine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000815	0.000815	CcSEcCtD
Deferoxamine—Angioedema—Betamethasone—atopic dermatitis	0.000803	0.000803	CcSEcCtD
Deferoxamine—Angioedema—Dexamethasone—atopic dermatitis	0.000803	0.000803	CcSEcCtD
Deferoxamine—Nausea—Tacrolimus—atopic dermatitis	0.000799	0.000799	CcSEcCtD
Deferoxamine—Angiopathy—Prednisone—atopic dermatitis	0.000797	0.000797	CcSEcCtD
Deferoxamine—Immune system disorder—Prednisone—atopic dermatitis	0.000794	0.000794	CcSEcCtD
Deferoxamine—Oedema—Triamcinolone—atopic dermatitis	0.00079	0.00079	CcSEcCtD
Deferoxamine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00079	0.00079	CcSEcCtD
Deferoxamine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000788	0.000788	CcSEcCtD
Deferoxamine—Arrhythmia—Prednisone—atopic dermatitis	0.000785	0.000785	CcSEcCtD
Deferoxamine—Infection—Triamcinolone—atopic dermatitis	0.000785	0.000785	CcSEcCtD
Deferoxamine—Hypotension—Hydrocortisone—atopic dermatitis	0.000784	0.000784	CcSEcCtD
Deferoxamine—Infection—Methylprednisolone—atopic dermatitis	0.000783	0.000783	CcSEcCtD
Deferoxamine—Shock—Triamcinolone—atopic dermatitis	0.000777	0.000777	CcSEcCtD
Deferoxamine—Shock—Methylprednisolone—atopic dermatitis	0.000776	0.000776	CcSEcCtD
Deferoxamine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000773	0.000773	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisolone—atopic dermatitis	0.000771	0.000771	CcSEcCtD
Deferoxamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000771	0.000771	CcSEcCtD
Deferoxamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000769	0.000769	CcSEcCtD
Deferoxamine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000766	0.000766	CcSEcCtD
Deferoxamine—Erythema—Prednisone—atopic dermatitis	0.000765	0.000765	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000764	0.000764	CcSEcCtD
Deferoxamine—Convulsion—Dexamethasone—atopic dermatitis	0.000761	0.000761	CcSEcCtD
Deferoxamine—Convulsion—Betamethasone—atopic dermatitis	0.000761	0.000761	CcSEcCtD
Deferoxamine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000753	0.000753	CcSEcCtD
Deferoxamine—Myalgia—Dexamethasone—atopic dermatitis	0.000748	0.000748	CcSEcCtD
Deferoxamine—Myalgia—Betamethasone—atopic dermatitis	0.000748	0.000748	CcSEcCtD
Deferoxamine—Hypotension—Methylprednisolone—atopic dermatitis	0.000737	0.000737	CcSEcCtD
Deferoxamine—Pain—Prednisolone—atopic dermatitis	0.000735	0.000735	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000724	0.000724	CcSEcCtD
Deferoxamine—Vision blurred—Prednisone—atopic dermatitis	0.000721	0.000721	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00072	0.00072	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000718	0.000718	CcSEcCtD
Deferoxamine—Pain—Hydrocortisone—atopic dermatitis	0.000718	0.000718	CcSEcCtD
Deferoxamine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000717	0.000717	CcSEcCtD
Deferoxamine—Oedema—Betamethasone—atopic dermatitis	0.000717	0.000717	CcSEcCtD
Deferoxamine—Oedema—Dexamethasone—atopic dermatitis	0.000717	0.000717	CcSEcCtD
Deferoxamine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000717	0.000717	CcSEcCtD
Deferoxamine—Infection—Dexamethasone—atopic dermatitis	0.000712	0.000712	CcSEcCtD
Deferoxamine—Infection—Betamethasone—atopic dermatitis	0.000712	0.000712	CcSEcCtD
Deferoxamine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000709	0.000709	CcSEcCtD
Deferoxamine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000708	0.000708	CcSEcCtD
Deferoxamine—Shock—Dexamethasone—atopic dermatitis	0.000705	0.000705	CcSEcCtD
Deferoxamine—Shock—Betamethasone—atopic dermatitis	0.000705	0.000705	CcSEcCtD
Deferoxamine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000704	0.000704	CcSEcCtD
Deferoxamine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000703	0.000703	CcSEcCtD
Deferoxamine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000703	0.000703	CcSEcCtD
Deferoxamine—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000702	0.000702	CcSEcCtD
Deferoxamine—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000702	0.000702	CcSEcCtD
Deferoxamine—Tachycardia—Betamethasone—atopic dermatitis	0.0007	0.0007	CcSEcCtD
Deferoxamine—Tachycardia—Dexamethasone—atopic dermatitis	0.0007	0.0007	CcSEcCtD
Deferoxamine—Angioedema—Prednisone—atopic dermatitis	0.000699	0.000699	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000686	0.000686	CcSEcCtD
Deferoxamine—Urticaria—Prednisolone—atopic dermatitis	0.000683	0.000683	CcSEcCtD
Deferoxamine—Pain—Triamcinolone—atopic dermatitis	0.000676	0.000676	CcSEcCtD
Deferoxamine—Hypotension—Dexamethasone—atopic dermatitis	0.00067	0.00067	CcSEcCtD
Deferoxamine—Hypotension—Betamethasone—atopic dermatitis	0.00067	0.00067	CcSEcCtD
Deferoxamine—Urticaria—Hydrocortisone—atopic dermatitis	0.000667	0.000667	CcSEcCtD
Deferoxamine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000663	0.000663	CcSEcCtD
Deferoxamine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000663	0.000663	CcSEcCtD
Deferoxamine—Convulsion—Prednisone—atopic dermatitis	0.000663	0.000663	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000653	0.000653	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000653	0.000653	CcSEcCtD
Deferoxamine—Myalgia—Prednisone—atopic dermatitis	0.000651	0.000651	CcSEcCtD
Deferoxamine—Arthralgia—Prednisone—atopic dermatitis	0.000651	0.000651	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000647	0.000647	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000645	0.000645	CcSEcCtD
Deferoxamine—Paraesthesia—Betamethasone—atopic dermatitis	0.000644	0.000644	CcSEcCtD
Deferoxamine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000644	0.000644	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000633	0.000633	CcSEcCtD
Deferoxamine—Urticaria—Triamcinolone—atopic dermatitis	0.000628	0.000628	CcSEcCtD
Deferoxamine—Urticaria—Methylprednisolone—atopic dermatitis	0.000626	0.000626	CcSEcCtD
Deferoxamine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000625	0.000625	CcSEcCtD
Deferoxamine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000624	0.000624	CcSEcCtD
Deferoxamine—Oedema—Prednisone—atopic dermatitis	0.000624	0.000624	CcSEcCtD
Deferoxamine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000623	0.000623	CcSEcCtD
Deferoxamine—Infection—Prednisone—atopic dermatitis	0.00062	0.00062	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000619	0.000619	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000619	0.000619	CcSEcCtD
Deferoxamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000618	0.000618	CcSEcCtD
Deferoxamine—Shock—Prednisone—atopic dermatitis	0.000614	0.000614	CcSEcCtD
Deferoxamine—Pain—Dexamethasone—atopic dermatitis	0.000613	0.000613	CcSEcCtD
Deferoxamine—Pain—Betamethasone—atopic dermatitis	0.000613	0.000613	CcSEcCtD
Deferoxamine—Nervous system disorder—Prednisone—atopic dermatitis	0.000612	0.000612	CcSEcCtD
Deferoxamine—Tachycardia—Prednisone—atopic dermatitis	0.000609	0.000609	CcSEcCtD
Deferoxamine—Skin disorder—Prednisone—atopic dermatitis	0.000606	0.000606	CcSEcCtD
Deferoxamine—Pruritus—Hydrocortisone—atopic dermatitis	0.000594	0.000594	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000586	0.000586	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000586	0.000586	CcSEcCtD
Deferoxamine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000582	0.000582	CcSEcCtD
Deferoxamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000581	0.000581	CcSEcCtD
Deferoxamine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000574	0.000574	CcSEcCtD
Deferoxamine—Urticaria—Betamethasone—atopic dermatitis	0.000569	0.000569	CcSEcCtD
Deferoxamine—Urticaria—Dexamethasone—atopic dermatitis	0.000569	0.000569	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000569	0.000569	CcSEcCtD
Deferoxamine—Dizziness—Prednisolone—atopic dermatitis	0.000568	0.000568	CcSEcCtD
Deferoxamine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000567	0.000567	CcSEcCtD
Deferoxamine—Abdominal pain—Betamethasone—atopic dermatitis	0.000567	0.000567	CcSEcCtD
Deferoxamine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000567	0.000567	CcSEcCtD
Deferoxamine—Body temperature increased—Betamethasone—atopic dermatitis	0.000567	0.000567	CcSEcCtD
Deferoxamine—Paraesthesia—Prednisone—atopic dermatitis	0.000561	0.000561	CcSEcCtD
Deferoxamine—Pruritus—Triamcinolone—atopic dermatitis	0.000559	0.000559	CcSEcCtD
Deferoxamine—Pruritus—Methylprednisolone—atopic dermatitis	0.000558	0.000558	CcSEcCtD
Deferoxamine—Dizziness—Hydrocortisone—atopic dermatitis	0.000555	0.000555	CcSEcCtD
Deferoxamine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000539	0.000539	CcSEcCtD
Deferoxamine—Headache—Prednisolone—atopic dermatitis	0.000538	0.000538	CcSEcCtD
Deferoxamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000533	0.000533	CcSEcCtD
Deferoxamine—Headache—Hydrocortisone—atopic dermatitis	0.000526	0.000526	CcSEcCtD
Deferoxamine—Dizziness—Triamcinolone—atopic dermatitis	0.000522	0.000522	CcSEcCtD
Deferoxamine—Dizziness—Methylprednisolone—atopic dermatitis	0.000521	0.000521	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000511	0.000511	CcSEcCtD
Deferoxamine—Nausea—Prednisolone—atopic dermatitis	0.00051	0.00051	CcSEcCtD
Deferoxamine—Pruritus—Dexamethasone—atopic dermatitis	0.000507	0.000507	CcSEcCtD
Deferoxamine—Pruritus—Betamethasone—atopic dermatitis	0.000507	0.000507	CcSEcCtD
Deferoxamine—Vomiting—Triamcinolone—atopic dermatitis	0.000502	0.000502	CcSEcCtD
Deferoxamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000501	0.000501	CcSEcCtD
Deferoxamine—Nausea—Hydrocortisone—atopic dermatitis	0.000498	0.000498	CcSEcCtD
Deferoxamine—Urticaria—Prednisone—atopic dermatitis	0.000496	0.000496	CcSEcCtD
Deferoxamine—Headache—Triamcinolone—atopic dermatitis	0.000495	0.000495	CcSEcCtD
Deferoxamine—Headache—Methylprednisolone—atopic dermatitis	0.000494	0.000494	CcSEcCtD
Deferoxamine—Body temperature increased—Prednisone—atopic dermatitis	0.000494	0.000494	CcSEcCtD
Deferoxamine—Abdominal pain—Prednisone—atopic dermatitis	0.000494	0.000494	CcSEcCtD
Deferoxamine—Diarrhoea—Dexamethasone—atopic dermatitis	0.00049	0.00049	CcSEcCtD
Deferoxamine—Diarrhoea—Betamethasone—atopic dermatitis	0.00049	0.00049	CcSEcCtD
Deferoxamine—Dizziness—Dexamethasone—atopic dermatitis	0.000474	0.000474	CcSEcCtD
Deferoxamine—Dizziness—Betamethasone—atopic dermatitis	0.000474	0.000474	CcSEcCtD
Deferoxamine—Nausea—Triamcinolone—atopic dermatitis	0.000469	0.000469	CcSEcCtD
Deferoxamine—Nausea—Methylprednisolone—atopic dermatitis	0.000468	0.000468	CcSEcCtD
Deferoxamine—Hypersensitivity—Prednisone—atopic dermatitis	0.00046	0.00046	CcSEcCtD
Deferoxamine—Vomiting—Dexamethasone—atopic dermatitis	0.000456	0.000456	CcSEcCtD
Deferoxamine—Vomiting—Betamethasone—atopic dermatitis	0.000456	0.000456	CcSEcCtD
Deferoxamine—Headache—Dexamethasone—atopic dermatitis	0.000449	0.000449	CcSEcCtD
Deferoxamine—Headache—Betamethasone—atopic dermatitis	0.000449	0.000449	CcSEcCtD
Deferoxamine—Pruritus—Prednisone—atopic dermatitis	0.000442	0.000442	CcSEcCtD
Deferoxamine—Diarrhoea—Prednisone—atopic dermatitis	0.000427	0.000427	CcSEcCtD
Deferoxamine—Nausea—Betamethasone—atopic dermatitis	0.000426	0.000426	CcSEcCtD
Deferoxamine—Nausea—Dexamethasone—atopic dermatitis	0.000426	0.000426	CcSEcCtD
Deferoxamine—Dizziness—Prednisone—atopic dermatitis	0.000413	0.000413	CcSEcCtD
Deferoxamine—Vomiting—Prednisone—atopic dermatitis	0.000397	0.000397	CcSEcCtD
Deferoxamine—Headache—Prednisone—atopic dermatitis	0.000391	0.000391	CcSEcCtD
Deferoxamine—Nausea—Prednisone—atopic dermatitis	0.000371	0.000371	CcSEcCtD
